Folate-Functionalized Mesoporous Hollow SnO₂ Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy

Figure 9

(a) The tumor volume of the control group, PTX group, SNFP group, and SFNFP group. Data represented as mean ± SD (n=3). (b) Images of tumors from each treatment group following excision on day 21.

(a)

(b)